Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$866,494
-$143,936 QoQ
Shares Held
35,984
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,412
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOWEN HANES & CO INC holds $152,182,717 across 7 Drug Manufacturers - General names. PFE ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,646 | $137,509,863 | |
| 2 | JNJ |
Johnson & Johnson
|
36,439 | $9,254,412 | |
| 3 | ABBV |
AbbVie Inc.
|
12,440 | $3,130,401 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,445 | $947,560 | |
| 5 | PFE |
Pfizer Inc
This page
|
35,984 | $866,494 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,204 | $283,214 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,510 | $190,773 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $866,494 | 35,984 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,010,430 | 35,984 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $896,001 | 35,984 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,130,904 | 44,384 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,119,500 | 46,184 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,170,302 | 46,184 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,225,261 | 46,184 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,778,970 | 61,471 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,803,898 | 64,471 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,796,701 | 64,746 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,864,037 | 64,746 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,359,348 | 71,129 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,432,947 | 66,329 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,700,103 | 66,179 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,407,664 | 66,504 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,507,404 | 57,299 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,412,246 | 84,155 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,317,876 | 83,405 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,075,642 | 85,955 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,873,136 | 90,052 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,529,177 | 90,122 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,265,120 | 90,122 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,317,390 | 90,122 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,039,380 | 82,817 | Shares | Sole | 2021-02-08 | |
| 2020-06-30 | $2,651,874 | 81,097 | Shares | Sole | 2021-02-08 | |
| 2020-03-31 | $2,286,494 | 70,052 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||